Autolus Therapeutics PLC
NASDAQ:AUTL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.18
7.29
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Autolus Therapeutics PLC
Wall Street
Price Targets
AUTL Price Targets Summary
Autolus Therapeutics PLC
According to Wall Street analysts, the average 1-year price target for
AUTL
is 10.57 USD
with a low forecast of 7.68 USD and a high forecast of 13.65 USD.
AUTL Last Price Targets
Autolus Therapeutics PLC
The latest public price target was made on Nov 18, 2024 by
Graig Suvannavejh
from
Goldman Sachs
,
who expects
AUTL
stock to
rise by 249%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Graig Suvannavejh
Goldman Sachs
|
7.6
USD
Upside 249% |
1 month ago
Nov 18, 2024
|
Goldman Sachs Upgrades Autolus Therapeutics plc (AUTL) to Buy
StreetInsider
|
Yanan Zhu
Wells Fargo
|
8
USD
Upside 267% |
7 months ago
May 20, 2024
|
Wells Fargo Reiterates Overweight Rating on Autolus Therapeutics plc (AUTL)
StreetInsider
|
Asthika Goonewardene
Truist Financial
|
11
USD
Upside 405% |
8 months ago
Apr 8, 2024
|
Autolus Therapeutics plc (AUTL) PT Raised to $11 at Truist Securities
StreetInsider
|
|
Asthika Goonewardene
Truist Financial
|
10
USD
Upside 359% |
9 months ago
Mar 15, 2024
|
Autolus Therapeutics plc (AUTL) PT Raised to $10 at Truist Securities
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AUTL's stock price target?
Price Target
10.57
USD
According to Wall Street analysts, the average 1-year price target for
AUTL
is 10.57 USD
with a low forecast of 7.68 USD and a high forecast of 13.65 USD.
What is Autolus Therapeutics PLC's Revenue forecast?
Projected CAGR
267%
For the last 6 years the
compound annual growth rate for
Autolus Therapeutics PLC's revenue is
0%.
The projected
CAGR
for the next 4 years is
267%.
You don't have any saved screeners yet
